Pricing Log in Create free account
Saturday 17 October 2026 Export RMD’s income statement to Excel — free account

ResMed Inc.

RMD Healthcare Medical Instruments & Supplies

ResMed Inc.’s revenue for fiscal 2026 (year ended June 2026) was $5.7 billion, up 9.85% from fiscal 2025. In the quarter to June 2026, revenue grew 8.58%, EPS grew 2.32%, free cash flow fell 21.3% and total debt fell 39.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.

238.97 3.26 −1.35%
Market cap
$34.1B
P/E
22.8×
Fwd P/E
16.6×
Dividend yield
1.03%
F-score
6/9
Altman Z
10.00
Beneish M
−2.59
Dividend safety
96/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

ResMed Inc. (RMD) P/S ratio

Alert me on P/S ratio

As of 16 October 2026, ResMed Inc. (RMD) trades at a P/S ratio of 6.2×. Over the past ten years it has ranged from 4.1× (January 2016) to 13.5× (September 2021); the current reading is higher than 39% of that period. That is above the Medical Instruments & Supplies industry median of 2.5× and above the Healthcare sector median of 3.4×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2026 5.0× (31.80%)
FY2025 7.4× 25.39%
FY2024 5.9× (22.75%)
FY2023 7.6× (11.26%)
FY2022 8.6× (23.63%)
FY2021 11.2× 19.57%
FY2020 9.4× 37.93%
FY2019 6.8× 7.33%
FY2018 6.3× 18.87%
FY2017 5.3× 10.44%

Quarterly newest first

Period P/S ratio Change
Jun 2026 5.0× (14.86%)
Mar 2026 5.9× (9.47%)
Dec 2025 6.5× (14.50%)
Sep 2025 7.6× 3.48%
42 more quarters

Against its own ten years

Low 4.1× High 13.5×
Ten-year median 6.7×
Current reading's percentile 35

P/S ratio against peers

Company P/S ratio
MDLN Medline Inc. compare 1.0×
BAX Baxter International Inc. compare 1.1×
SOLV Solventum Corporation compare 1.8×
BDX Becton, Dickinson and Company compare 2.4×
COO The Cooper Companies, Inc. compare 2.6×
ALC Alcon compare 3.0×
RMD ResMed Inc. 6.2×
WST West Pharmaceutical Services, Inc. compare 8.1×
RGEN Repligen Corporation compare 12.6×
Medical Instruments & Supplies industry median 2.5×
Healthcare sector median 3.4×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on RMD